Fundraising FoxAbell Foundation, Inc. — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Baltimore-based immunology company focused on treatments for cancer and autoimmune disorders; raised an $11.5 million Series C led by First In Ventures.
BiotechBaltimore, US
David S. Block(Co-Founder & CEO)Elizabeth C. Block(Executive Officer)Raymond Shinazi(Director)Joseph Klein(Director)Mark Lerner(Director)
BoardCharles Polsky(Director)
Co-investorsBrace PharmaFirst In Ventures
Minnowtech develops precision aquaculture technology using integrated sensor-based systems to help aquafarmers assess and maximize their cultivation efforts.
AgTechFoodTechHardwareIoTBaltimore, US
Suzan Shahrestani(Founder)inKelli Booth(Co-Founder & CEO)inKen Malone(Co-Founder)inQuynh Vo(Chief Technology Officer)in
Co-investorsMaryland TEDCOTCP Venture CapitalTEDCOUniversity System of Maryland Momentum FundBlue Revolution Investments G.P.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.